Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 33 | 16 | 18 |
| Accounts receivable | -22 | -14 | 16 |
| Other Working Capital | 9 | 42 | -40 |
| Other Operating Activity | -829 | -548 | -400 |
| Operating Cash Flow | $-809 | $-503 | $-405 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -300 | -4 | -13 |
| Other Investing Activity | 0 | -74 | 725 |
| Investing Cash Flow | $-300 | $-78 | $712 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 1,215 | 33 | N/A |
| Financing Cash Flow | $1,215 | $33 | $0 |
| Beginning Cash Position | 276 | 824 | 517 |
| End Cash Position | 382 | 276 | 824 |
| Net Cash Flow | $106 | $-548 | $307 |
| Free Cash Flow | |||
| Operating Cash Flow | -809 | -503 | -405 |
| Capital Expenditure | -315 | -4 | -13 |
| Free Cash Flow | -1,124 | -508 | -417 |